Inside Track: Reimbursement at the Molecular Level
The Protecting Access to Medicare Act of 2014 incorporates fundamental changes to the way that the Centers for Medicare & Medicaid Services will handle future coding and payment issues for lab testing. To understand the ongoing reimbursement concerns of molecular pathologists, CLP visited with Mary Steele Williams, executive director of the Association for Molecular Pathology.
Read More